Results 131 to 140 of about 82,322 (154)

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Journal of the American Medical Association, 1960
openaire   +2 more sources

Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Therapeutics and Clinical Risk Management, 2021
Carmelo Gurnari, Simona Pagliuca
exaly  

Safety of current treatments for paroxysmal nocturnal hemoglobinuria

Expert Opinion on Drug Safety, 2021
Sung-Eun Lee, Jong Wook Lee
exaly  

Emerging drugs for the treatment of paroxysmal nocturnal hemoglobinuria

Expert Opinion on Emerging Drugs, 2022
Flore Sicre de Fontbrune
exaly  

Leukemia Arising out of Paroxysmal Nocturnal Hemoglobinuria

Leukemia and Lymphoma, 1999
Edward Medof, James Eshleman, M E Medof   +2 more
exaly  

Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.

Journal of Experimental Medicine, 1983
Robert Schreiber
exaly  

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Therapeutic Advances in Hematology, 2019
Robert Stern, Nathan Connell
exaly  

Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Expert Opinion on Biological Therapy, 2020
Jong Wook Lee, Austin Kulasekararaj
exaly  

Research directions in paroxysmal nocturnal hemoglobinuria

Trends in Immunology, 1999
Russell Ware, Charles J Parker
exaly  

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: Findings from a cohort study

Journal of Hepatology, 2009
Aurélie Plessier, Sarwa Darwish Murad, Elwyn Elias   +2 more
exaly